HIV Persists in Late Coronary Atheroma and is Associated with Increased Local Inflammation and Disease Progression

Chronic inflammation contributes to the prevalence of cardiovascular disease in people living with HIV (PLWH). The immune mechanisms driving atherosclerosis progression in PLWH remain unclear. This study conducted comprehensive assessments of medium-sized coronary arteries and aorta from deceased PLWH and controls without HIV using DNA/RNA assays, spatial transcriptomics, and high-resolution mass spectrometry. Findings revealed more significant inflammation correlated with higher HIV copy numbers in late atheroma of PLWH. Enhanced and decreased expression in CD163 macrophages were co-localized in coronaries of PLWH, suggesting a reduction in plasma lipoprotein clearance compared to controls. Spatial analyses identified potential therapeutic targets by revealing inflammatory changes in medium-sized arteries and the aorta. We examined the relationship between atherosclerotic phenotypes and inflammatory gene expression in Vanderbilts Biobank to study these findings in a larger clinical cohort. This established a significant association between and gene expressions with atherosclerosis, partly influenced by HIV.

References

Hsue P, Hunt P, Schnell A, Kalapus S, Hoh R, Ganz P . Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS. 2009; 23(9):1059-67. PMC: 2691772. DOI: 10.1097/QAD.0b013e32832b514b. View

Hunt P, Brenchley J, Sinclair E, McCune J, Roland M, Page-Shafer K . Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis. 2008; 197(1):126-33. PMC: 3466592. DOI: 10.1086/524143. View

Aarup A, Pedersen T, Junker N, Christoffersen C, Bartels E, Madsen M . Hypoxia-Inducible Factor-1α Expression in Macrophages Promotes Development of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2016; 36(9):1782-90. DOI: 10.1161/ATVBAHA.116.307830. View

Lv T, Cao W, Li T . HIV-Related Immune Activation and Inflammation: Current Understanding and Strategies. J Immunol Res. 2021; 2021:7316456. PMC: 8494587. DOI: 10.1155/2021/7316456. View

Nolan D, Watts G, Herrmann S, French M, John M, Mallal S . Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk?. QJM. 2003; 96(11):825-32. DOI: 10.1093/qjmed/hcg145. View

Sakamoto A, Kawakami R, Mori M, Guo L, Paek K, Mosquera J . CD163+ macrophages restrain vascular calcification, promoting the development of high-risk plaque. JCI Insight. 2023; 8(5). PMC: 10077470. DOI: 10.1172/jci.insight.154922. View

He S, Bhatt R, Brown C, Brown E, Buhr D, Chantranuvatana K . High-plex imaging of RNA and proteins at subcellular resolution in fixed tissue by spatial molecular imaging. Nat Biotechnol. 2022; 40(12):1794-1806. DOI: 10.1038/s41587-022-01483-z. View

Gey K, Ducimetiere P, Evans A, Amouyel P, Arveiler D, Ferrieres J . Low plasma retinol predicts coronary events in healthy middle-aged men: the PRIME Study. Atherosclerosis. 2009; 208(1):270-4. DOI: 10.1016/j.atherosclerosis.2009.07.018. View

Mujawar Z, Rose H, Morrow M, Pushkarsky T, Dubrovsky L, Mukhamedova N . Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol. 2006; 4(11):e365. PMC: 1629034. DOI: 10.1371/journal.pbio.0040365. View

10.

Mack T, Vlasschaert C, von Beck K, Silver A, Heimlich J, Poisner H . Cost-Effective and Scalable Clonal Hematopoiesis Assay Provides Insight into Clonal Dynamics. J Mol Diagn. 2024; 26(7):563-573. PMC: 11536471. DOI: 10.1016/j.jmoldx.2024.03.007. View

11.

Liu Q, Hsu C, Shyr Y . Scalable and model-free detection of spatial patterns and colocalization. Genome Res. 2022; 32(9):1736-1745. PMC: 9528978. DOI: 10.1101/gr.276851.122. View

12.

Freiberg M, Chang C, Kuller L, Skanderson M, Lowy E, Kraemer K . HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013; 173(8):614-22. PMC: 4766798. DOI: 10.1001/jamainternmed.2013.3728. View

13.

Danciu I, Cowan J, Basford M, Wang X, Saip A, Osgood S . Secondary use of clinical data: the Vanderbilt approach. J Biomed Inform. 2014; 52:28-35. PMC: 4133331. DOI: 10.1016/j.jbi.2014.02.003. View

14.

Decout A, Katz J, Venkatraman S, Ablasser A . The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol. 2021; 21(9):548-569. PMC: 8029610. DOI: 10.1038/s41577-021-00524-z. View

15.

Wang L, Xing X, Chen L, Yang L, Su X, Rabitz H . Peak Annotation and Verification Engine for Untargeted LC-MS Metabolomics. Anal Chem. 2018; 91(3):1838-1846. PMC: 6501219. DOI: 10.1021/acs.analchem.8b03132. View

16.

Ajamian L, Abrahamyan L, Milev M, Ivanov P, Kulozik A, Gehring N . Unexpected roles for UPF1 in HIV-1 RNA metabolism and translation. RNA. 2008; 14(5):914-27. PMC: 2327365. DOI: 10.1261/rna.829208. View

17.

Zhou W, Lin J, Chen H, Wang J, Liu Y, Xia M . Retinoic acid induces macrophage cholesterol efflux and inhibits atherosclerotic plaque formation in apoE-deficient mice. Br J Nutr. 2015; 114(4):509-18. DOI: 10.1017/S0007114515002159. View

18.

Burdo T, Lo J, Abbara S, Wei J, DeLelys M, Preffer F . Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis. 2011; 204(8):1227-36. PMC: 3203384. DOI: 10.1093/infdis/jir520. View

19.

Sviridov D, Mukhamedova N, Makarov A, Adzhubei A, Bukrinsky M . Comorbidities of HIV infection: role of Nef-induced impairment of cholesterol metabolism and lipid raft functionality. AIDS. 2019; 34(1):1-13. PMC: 6903377. DOI: 10.1097/QAD.0000000000002385. View

20.

Scrucca L, Fop M, Murphy T, Raftery A . mclust 5: Clustering, Classification and Density Estimation Using Gaussian Finite Mixture Models. R J. 2016; 8(1):289-317. PMC: 5096736. View